Rejuvenate Bio is a biotechnology company that develops therapies to reverse aging and treat age-related diseases.
Rejuvenate Bio has raised $6.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2026.
Rejuvenate Bio's investors include Connecticut Innovations, Digitalis Ventures, KdT Ventures, California Institute for Regenerative Medicine, Kendall Capital Partners.
Rejuvenate Bio is headquartered in San Diego, United States.
Rejuvenate Bio is a biotechnology company that develops therapies to reverse aging and treat age-related diseases.
Rejuvenate Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Rejuvenate Bio — Funding & Investors." VCBacked, June 8, 2026, https://www.vcbacked.co/company/rejuvenate-bio. Accessed August 14, 2026.
VCBacked. (2026). Rejuvenate Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/rejuvenate-bio
{{cite web |title=Rejuvenate Bio — Funding & Investors |url=https://www.vcbacked.co/company/rejuvenate-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated